Future research should investigate targeted interventions for biomarker dysregulations, including antioxidant therapies to boost glutathione levels or BDNF-enhancing approaches (e.g., exercise, selective serotonin reuptake inhibitors, or neuromodulation) to improve sleep and symptom management in PTSD. The gene discussed is BDNF; the disease is post-traumatic stress disorder.